Evommune, Inc. (EVMN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 10M | 0 | 3M | 0 |
| Revenue Growth % | -100% | - | - | - | - | - |
| Cost of Goods Sold | 349K | 0 | 0 | 375K | 377K | 0 |
| COGS % of Revenue | - | - | - | - | 12.57% | - |
| Gross Profit | -349K | 0 | 10M | -375K | 2.62M | 0 |
| Gross Margin % | - | - | 100% | - | 87.43% | - |
| Gross Profit Growth % | -113.31% | - | - | - | - | - |
| Operating Expenses | 23.61M | 29.72M | 23.33M | 22.62M | 17.66M | 18.98M |
| OpEx % of Revenue | - | - | 233.28% | - | 588.5% | - |
| Selling, General & Admin | 6.29M | 9.31M | 3.69M | 3.36M | 3.29M | 3.43M |
| SG&A % of Revenue | - | - | 36.89% | - | 109.77% | - |
| Research & Development | 17.32M | 20.4M | 19.64M | 19.64M | 14.36M | 15.56M |
| R&D % of Revenue | - | - | 196.39% | - | 478.73% | - |
| Other Operating Expenses | 0 | 0 | 0 | -375K | 0 | 0 |
| Operating Income | -23.95M | -29.72M | -13.33M | -22.99M | -15.03M | -18.98M |
| Operating Margin % | - | - | -133.28% | - | -501.07% | - |
| Operating Income Growth % | -59.35% | -56.52% | - | - | - | - |
| EBITDA | -23.61M | -29.39M | -13.02M | -22.62M | -14.65M | -18.64M |
| EBITDA Margin % | - | - | -130.17% | - | -488.5% | - |
| EBITDA Growth % | -61.07% | -57.68% | - | - | - | - |
| D&A (Non-Cash Add-back) | 349K | 326K | 311K | 375K | 377K | 345.5K |
| EBIT | -21.67M | -28.27M | -12.47M | -13.56M | -14.55M | -18.32M |
| Net Interest Income | 2.28M | 1.44M | 862K | 401K | 609K | 727K |
| Interest Income | 2.28M | 1.44M | 862K | 404K | 613K | 727K |
| Interest Expense | 0 | 0 | 0 | 3K | 4K | 0 |
| Other Income/Expense | 2.28M | 1.44M | 853K | 9.43M | 475K | 664K |
| Pretax Income | -21.67M | -28.27M | -12.47M | -13.56M | -14.56M | -18.32M |
| Pretax Margin % | - | - | -124.75% | - | -485.23% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -21.67M | -28.27M | -12.47M | -13.56M | -14.56M | -18.32M |
| Net Margin % | - | - | -124.75% | - | -485.23% | - |
| Net Income Growth % | -48.89% | -54.32% | - | - | - | - |
| Net Income (Continuing) | -21.67M | -28.27M | -12.47M | -13.56M | -14.56M | -18.32M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.64 | -0.90 | -0.40 | -0.45 | -0.48 | -0.63 |
| EPS Growth % | -33.33% | -42.86% | - | - | - | - |
| EPS (Basic) | -0.64 | -0.90 | -0.40 | -0.45 | -0.48 | -0.63 |
| Diluted Shares Outstanding | 33.67M | 31.52M | 31.52M | 30.08M | 30.08M | 30.08M |
| Basic Shares Outstanding | 33.67M | 31.52M | 31.52M | 30.08M | 30.08M | 30.08M |
| Dividend Payout Ratio | - | - | - | - | - | - |